Hippocratic AI raises $141M to staff hospitals with clinical AI agents

Story Partners with Stability AI to Empower Open-Source Innovation for Creators and Developers

Meanwhile, Kristina Dulaney, RN, PMH-C, the founder of Cherished Mom, an organization dedicated to solving maternal mental health challenges, helped to create an AI agent that’s focused on helping new mothers navigate such problems with postpartum mental health assessments and depression screening. The startup was initially focused on creating generative AI chatbots to support clinicians and other healthcare professionals, but has since switched its focus to patients themselves. Its most advanced models take advantage of the latest developments in AI agents, which are a form of AI that can perform more complex tasks while working unsupervised. Despite rapid advancements in AI, creators in open-source ecosystems face significant challenges in monetizing derivative works and securing proper attribution.

Story, the global intellectual property blockchain, has announced its integration with Stability AI’s state-of-the-art models to revolutionize open-source AI development. This collaboration enables creators, developers, and artists to capture the value they contribute to the AI ecosystem by leveraging blockchain technology to ensure proper attribution, tracking, and monetization of creative works generated through AI. Andreessen Horowitz, or a16z, is investing in AI and biotech to lead the way in innovation.

Your vote of support is important to us and it helps us keep the content FREE.

In a statement, Raspberry AI said the funding would be used to accelerate its product development and add top engineering, sales and marketing talent to its team. But with U.S. companies raising and/or spending record sums on new AI infrastructure that many experts have noted depreciate rapidly (due to hardware/chip and software advancements), the question remains which vision of the future will win out in the end to become the dominant AI provider for the world. Or maybe it will always be a multiplicity of models each with a smaller market share? That’s followed by more extensive evaluations and safety assessments by an extensive network of more than 6,000 nurses and 300 doctors, who will confirm that it passes all required safety tests.

Once the AI agent is up and running, the clinicians who created it will be able to claim a share of the revenue it generates from the startup’s customers. Currently the technology is being used by Under Armour, MCM Worldwide, Gruppo Teddy and Li & Fung to create and iterate apparel, footwear and accessories styles. The company’s existing investors Greycroft, Correlation Ventures and MVP Ventures also joined in the round, along with notable angel investors, including Gokul Rajaram and Ken Pilot. Clearly, even as he espouses a commitment to open source AI, Zuck is not convinced that DeepSeek’s approach of optimizing for efficiency while leveraging far fewer GPUs than major labs is the right one for Meta, or for the future of AI.

Raspberry AI secures 24 million US dollars in funding round

Story is the world’s intellectual property blockchain, transforming IP into networks that transcend mediums and platforms, unleashing global creativity and liquidity. By integrating Stability AI’s advanced models, Story is taking a significant step toward building a fair and sustainable internet for creators and developers in the age of generative AI. Hippocratic AI said it’s necessary to have clinicians onboard because they have, over the course of their careers, developed deep expertise in their respective fields, as well as the practical insights to help cure specific medical conditions and the clinical workflows involved.

Investing in Raspberry AI – Andreessen Horowitz

Investing in Raspberry AI.

Posted: Mon, 13 Jan 2025 08:00:00 GMT [source]

Story aims to bridge this gap by combining Stability AI’s cutting-edge technology with blockchain’s ability to secure digital property rights. For example, creators could register unique styles or voices as intellectual property on Story with transparent usage terms. This would enable others to train and fine-tune AI models using this IP, ensuring that all contributors in the creative chain benefit when outputs are monetized.

One click below supports our mission to provide free, deep, and relevant content.

Holger Mueller of Constellation Research Inc. said Hippocratic AI is bringing two of the leading technology trends to the healthcare industry, namely no-code or low-code software development and AI agents. The launch is a bold step forward in healthcare innovation, giving clinicians the opportunity to participate in the design of AI agents that can address various aspects of patient care. It says clinicians can create an AI agent prototype that specializes in their area of focus in less than 30 minutes, and around three to four hours to develop one that can be tested. Shah said the last nine months since the company’s previous $50 million funding round have seen it make tremendous progress. During that time, it has received its first U.S. patents, fully evaluated and verified the safety of its first AI healthcare agents, and signed contracts with 23 health systems, payers and pharma clients.

For instance, one of its AI agents is specialized in chronic care management, medication checks and post-discharge follow-up regarding specific conditions such as kidney failure and congestive heart failure. The healthcare-focused artificial intelligence startup Hippocratic AI Inc. said today it has closed on a $141 million Series B funding round that brings its total amount raised to more than $278 million. “This round of financing will accelerate the development and deployment of the Hippocratic generative AI-driven super staffing and continue our quest to make healthcare abundance a reality,” he promised. Raspberry AI, the generative AI platform for fashion creatives, has secured 24 million US dollars in Series A funding led by Andreessen Horowitz (a16z). Today, we’re going in-depth on blockchain innovation with Robert Roose, an entrepreneur who’s on a mission to fix today’s broken monetary system. Hippocratic AI’s early customers include Arkos Health Inc., Belong Health Inc., Cincinnati Children’s, Fraser Health Authority (Canada), GuideHealth, Honor Health, Deca Dental Management, LLC, OhioHealth, WellSpan Health and other well-known healthcare systems and hospitals.

By incorporating this wisdom into its AI agents, it’s making them safer and improving patient outcomes, it said. Crucially, any agent created using its platform will undergo extensive safety training by both the creator and Hippocratic AI’s own staff. Every clinician will have access to a dashboard to track their AI agent’s performance and use and receive feedback for further development.

All these indicate the commitment a16z has in shaping the future of technology and healthcare through strategic investments. Both platforms use Stability AI’s models to bring creators’ visions to life and Story’s blockchain technology to enable provenance and attribution throughout the creative process. These real-world applications highlight how creators can safeguard their intellectual property while thriving in a shared creative economy. Raspberry AI offers brands and manufacturing creative teams technology solutions, which can help accelerate each stage of the fashion product development cycle to increase speed to market and profitability while reducing costs. Andreessen Horowitz, or a16z, is one of the leading AI investors and targets only innovative startups. They participated in the round that funded Anysphere on January 14, 2025, with a total sum of $105 million for an AI coding tool known as Cursor, whose valuation has reached $2.5 billion.

Onyxcoin (XCN) Market Trends and Ozak AI’s Contribution to AI-Driven Blockchain

In order to ensure its AI agents can do their jobs safely, Hippocratic AI says it only works with licensed clinicians to develop them, taking steps to verify their qualifications and experience first. Once clinicians have built their agents, they’ll be submitted to the startup for an initial round of testing. Through the Hippocratic AI Agent App Store, healthcare organizations and hospitals will be able to access a range of specialized AI agents for different aspects of medical care.

The startup was co-founded by Chief Executive Officer and serial entrepreneur Munjal Shah and a group of physicians, hospital administrators, healthcare professionals and AI researchers from organizations including El Camino Health LLC, Johns Hopkins University, Stanford University, Microsoft Corp., Google and Nvidia Corp. PIP Labs, an initial core contributor to the Story Network, is backed by investors including a16z crypto, Endeavor, and Polychain. Co-founded by a serial entrepreneur with a $440M exit and DeepMind’s youngest PM, PIP Labs boasts a veteran founding executive team with expertise in consumer tech, generative AI, and Web3 infrastructure. The startup has also created other AI agents for tasks like pre- and post-surgery wound care, extreme heat wave preparation, home health checks, diabetes screening and education, and many more besides. The startup said its AI Agent creators include Dr. Vanessa Dorismond MD, MA, MAS, a distinguished obstetrician and gynecologist at El Camino Women’s Medical Group and Teal Health, who helped to create an AI agent that’s focused on cervical cancer check-ins and enhancing patient education. According to the startup, the objective of these AI agents is to try and solve the massive shortage of trained nurses, social workers and nutritionists in the healthcare industry, both in the U.S. and globally.

TechBullion

The same day, a16z also led a Series A investment in Slingshot AI, which has raised a total of $40 million to create a foundation model for psychology. Those investments highlight the commitment of the group to using AI to address important issues and are also focusing on how AI can improve different industries, including healthcare and consumer services. In general, a16z is committed to supporting AI innovations that could have a profound impact on society. We are thrilled to see our models used in Story’s blockchain technology to ensure proper attribution and reward contributors,” said Scott Trowbridge, Vice President of Stability AI. Others include Kacie Spencer, DNP, RN, the chief nursing officer at Adtalem Global Education Inc., who has more than 20 years of experience in emergency nursing and clinical education. Her AI agent is focused on patient education for the proper installation of child car seats.

It participated in an Anysphere round that had the company raising $105 million on January 14, 2025, when it pushed the valuation up to $2.5 billion. Beyond this, it has also released a $500 million Biotech Ecosystem Venture Fund with Eli Lilly to place a focus on health technologies, but with the aspect of innovative applications. On the same day, they led a Series A investment in Slingshot AI, a company that’s developing advanced generative AI technology for mental health. Additionally, a16z invested in Raspberry AI to bring generative AI to the front of fashion design and production. In December 2024, they envisioned a future in which AI was used aggressively in nearly all sectors.

• The startup said its AI Agent creators include Dr. Vanessa Dorismond MD, MA, MAS, a distinguished obstetrician and gynecologist at El Camino Women’s Medical Group and Teal Health, who helped to create an AI agent that’s focused on cervical cancer check-ins and enhancing patient education.
• Andreessen Horowitz, or a16z, is one of the leading AI investors and targets only innovative startups.
• Hippocratic AI said it’s necessary to have clinicians onboard because they have, over the course of their careers, developed deep expertise in their respective fields, as well as the practical insights to help cure specific medical conditions and the clinical workflows involved.
• It says clinicians can create an AI agent prototype that specializes in their area of focus in less than 30 minutes, and around three to four hours to develop one that can be tested.

Introduction to Finasteride

Finasteride is a popular medication used primarily to treat male pattern baldness and benign prostatic hyperplasia. Proper finasteride dosage is crucial for achieving optimal results while minimizing potential side effects.

Recommended Finasteride Dosage

For Male Pattern Baldness

The standard finasteride dosage for hair loss is typically 1 mg daily. This dosage has been proven effective in https://irishpowerpharma.com/product-category/oestrogenblocker-aromatasehemmer/finasterid/ promoting hair growth and preventing further loss in most men.

For Enlarged Prostate

In cases of benign prostatic hyperplasia, the typical finasteride dosage is usually 5 mg daily. This higher dose helps reduce prostate size and improve urinary symptoms.

Importance of Correct Finasteride Dosage

Determining the right finasteride dosage is essential to balance efficacy and safety. An inappropriate dose can lead to suboptimal results or unwanted side effects such as decreased libido or hormonal imbalances.

Consultation and Monitoring

Before starting finasteride, consulting with a healthcare professional is vital. Regular monitoring ensures that the finasteride dosage remains appropriate over time and allows adjustments if necessary.

Potential Side Effects and Precautions

While generally well-tolerated at prescribed doses, some individuals may experience side effects. Adherence to the recommended finasteride dosage minimizes risks and promotes safe use.

Conclusion

Proper understanding of finasteride dosage is key to maximizing its benefits for hair loss treatment or prostate health. Always follow medical advice to determine the appropriate dose tailored to individual needs.

Understanding uksteroids: Indications for Use in Sportsmen

The use of uksteroids among athletes has garnered significant attention due to their potential benefits and risks. Steroids are synthetic substances similar to the male sex hormone testosterone, and they can be utilized for various purposes in sports.

What Are uksteroids?

Uksteroids refer to a range of anabolic steroids available in the UK, often used by bodybuilders and competitive athletes to improve physical performance. These substances can enhance muscle mass, strength, and endurance, but they must be used responsibly.

Indications for Use in Sportsmen

Sportsmen may consider using uksteroids for several reasons:

• Muscle Growth: One of the primary indications for using uksteroids is to promote rapid muscle hypertrophy. Athletes looking to increase their muscle size often find these substances effective.
• Strength Enhancement: Athletes involved in strength sports may turn to uksteroids to boost their overall power and performance during competitions.
• Recovery Improvement: Anabolic steroids can help expedite recovery Tri-Trenbolone 200 mg Swiss Remedies from intense workouts, allowing athletes to train harder and more frequently.
• Increased Endurance: Some sportsmen use these steroids to improve their stamina, enabling them to perform better in endurance events.

Risks and Considerations

While there are clear indications for the use of uksteroids, it is crucial to note the associated risks. Possible side effects include hormonal imbalances, liver damage, cardiovascular issues, and psychological effects such as aggression and mood swings.

Legal and Ethical Aspects

The use of uksteroids in professional sports is heavily regulated, and athletes risk severe penalties, including bans, if caught using banned substances. It is essential for sportsmen to remain informed about the rules governing steroid use in their respective sports.

Conclusion

Understanding the indications for use of uksteroids in sportsmen offers insight into both the potential benefits and the considerable risks involved. Responsible usage, awareness of legal implications, and health considerations are paramount for any athlete contemplating the use of these substances.

Lovenox enoxaparin dosing, indications, interactions, adverse effects, and more

Closely monitor blood pressure and heart rate in these patients. Start at a lower starting dosage and increase the dosage every 4 to 6 weeks as needed based on clinical and laboratory response. By visiting Synthroid.com, patients can access additional support and resources to understand and manage their hypothyroidism. The Before Breakfast Club is a program designed to help support your patients on SYNTHROID therapy.

Patient Handout

RxList does not provide medical advice, diagnosis or treatment. You are encouraged to report negative side effects of prescription drugs to the FDA. Closely monitor infants during the first 2 weeks of SYNTHROID therapy for cardiac overload and arrhythmias.

Treat patients with adrenal insufficiency with replacement glucocorticoids prior to initiating treatment with SYNTHROID see CONTRAINDICATIONS. Titrate the dose of SYNTHROID carefully and monitor response to titration to avoid these effects see DOSAGE AND ADMINISTRATION. Consider the potential synthroid celexa for food or drug interactions and adjust the administration or dosage of SYNTHROID as needed see DOSAGE AND ADMINISTRATION, DRUG INTERACTIONS and CLINICAL PHARMACOLOGY. Concurrent use of tricyclic (e.g., amitriptyline) or tetracyclic (e.g., maprotiline) antidepressants and SYNTHROID may increase the therapeutic and toxic effects of both drugs, possibly due to increased receptor sensitivity to catecholamines.

SUPPORT FOR PATIENTS

Gray literature was also searched in repositories, websites OpenGrey and Google Scholar, and abstracts of major international congresses. Study quality was assessed with the Newcastle–Ottawa quality assessment scale for observational studies and the Risk Of Bias In Non-randomized Studies – of Interventions (ROBINS-I) tool was used. Many other medicines can be affected by your thyroid hormone levels. Certain other medicines may also increase or decrease the effects of Synthroid. If you become pregnant while taking Synthroid, do not stop taking the medicine without your doctor’s advice. Having low thyroid hormone levels during pregnancy could harm both mother and baby.

Levothyroxine is generally continued for life in these patients see WARNINGS AND PRECAUTIONS. Addition of levothyroxine therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing SYNTHROID see DRUG INTERACTIONS. SYNTHROID may reduce the therapeutic effects of digitalis glycosides. Serum digitalis glycoside levels may decrease when a hypothyroid patient becomes euthyroid, necessitating an increase in the dose of digitalis glycosides.

• Levoxyl treats hypothyroidism (low thyroid hormone) and treats or prevents goiter.
• Administer SYNTHROID to pediatric patients who cannot swallow intact tablets by crushing the tablet, suspending the freshly crushed tablet in a small amount (5 to 10 mL) of water and immediately administering the suspension by spoon or dropper.
• Atrial fibrillation is the most common of the arrhythmias observed with levothyroxine overtreatment in the elderly.
• Administer SYNTHROID at least 4 hours before or after drugs known to interfere with SYNTHROID absorption see DRUG INTERACTIONS.
• Regarding the quality assessment, six out of seven studies were considered at low risk of bias,25–28,31,38 while one37 was considered at moderate risk because of measurement of outcomes.
• Pregnant and lactating females need to discuss the dose and use of this medication with their caregivers.

levothyroxine

Dosage titration is based on serum TSH or free-T4 see Important Considerations For Dosing. SYNTHROID is indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. The timing of meals relative to your oral levothyroxine dose can affect the absorption of the medication. Therefore, levothyroxine should be taken on a consistent schedule with regard to time of day and relation to meals to avoid large fluctuations in blood levels, which may alter its effects.

Antidepressant Therapy

In addition, absorption of levothyroxine may be decreased and/or delayed by foods such as soybean flour, cotton seed meal, walnuts, dietary fiber, calcium, calcium fortified juices and grapefruit or grapefruit juice. These foods should be avoided within several hours of dosing if possible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor. Hypersensitivity reactions to inactive ingredients have occurred in patients treated with thyroid hormone products. These include urticaria, pruritus, skin rash, flushing, angioedema, various gastrointestinal symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness, and wheezing.

Hypersensitivity to levothyroxine itself is not known to occur. Synthroid is prescribed in tablets that range from 25 to 300 mcg in strength and is usually taken once a day with a full glass of water (about 8 ounces) 30 to 60 minutes before breakfast for best adsorption into the body. Children can take the medicine if the tablet is crushed and put into about 1 to 2 teaspoons of water; do not store or delay giving this crushed pill suspension. Doctors often may have to slowly increase the dose; patients should not increase or decrease this medication themselves. Because some preparations of the drug may contain iodine or lactose, patients should tell their doctors about such allergies or reactions to these components.

Drug Interactions between levothyroxine and Lovenox

• Initiation of thyroid hormone therapy prior to initiating glucocorticoid therapy may precipitate an acute adrenal crisis in patients with adrenal insufficiency.
• To minimize the risk of hyperactivity, start at one-fourth the recommended full replacement dosage, and increase on a weekly basis by one-fourth the full recommended replacement dosage until the full recommended replacement dosage is reached.
• Carefully monitor glycemic control, especially when thyroid therapy is started, changed, or discontinued see WARNINGS AND PRECAUTIONS.

Get medical help right away, if you have any of the symptoms listed above. This section collects any data citations, data availability statements, or supplementary materials included in this article. Adding plans allows you to compare formulary status to other drugs in the same class. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Synthroid only for the indication prescribed. Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Euthyrox (levothyroxine) is used to treat hypothyroidism and to treat or prevent goiter. Armour Thyroid is used for hashimoto’s disease, hypothyroidism, after thyroid removal, thyroid … You may not be able to take Synthroid if you have certain medical conditions. Tell your doctor if you have an untreated or uncontrolled adrenal gland disorder, a thyroid disorder called thyrotoxicosis, or if you have any recent or current symptoms of a heart attack.